vs
Esperion Therapeutics, Inc.（ESPR）与Revolve Group, Inc.（RVLV）财务数据对比。点击上方公司名可切换其他公司
Revolve Group, Inc.的季度营收约是Esperion Therapeutics, Inc.的1.9倍（$324.4M vs $168.4M），Esperion Therapeutics, Inc.同比增速更快（143.7% vs 10.4%），过去两年Esperion Therapeutics, Inc.的营收复合增速更高（10.6% vs 9.5%）
Esperion Therapeutics, Inc.是一家上市美国药企，专注开发用于降低低密度脂蛋白胆固醇的口服小分子药物苯哌多酸，公司总部位于密歇根州安娜堡，目前核心研发管线围绕这款降脂创新药物推进，深耕血脂异常治疗领域的创新药物开发。
Revolve Theatre Company是总部位于英国泰晤士河畔亨利的剧团，专注于创作演出政治题材和莎士比亚系列戏剧作品，由奥利弗·登奇、乔·莫里斯与汤姆·史密斯共同创立运营。
ESPR vs RVLV — 直观对比
营收规模更大
RVLV
是对方的1.9倍
$168.4M
营收增速更快
ESPR
高出133.3%
10.4%
两年增速更快
ESPR
近两年复合增速
9.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $168.4M | $324.4M |
| 净利润 | — | $18.6M |
| 毛利率 | — | 53.3% |
| 营业利润率 | 50.6% | 6.3% |
| 净利率 | — | 5.7% |
| 营收同比 | 143.7% | 10.4% |
| 净利润同比 | — | 50.4% |
| 每股收益（稀释后） | $0.32 | $0.27 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ESPRRVLV
| Q4 25 | $168.4M | $324.4M | ||
| Q3 25 | $87.3M | $295.6M | ||
| Q2 25 | $82.4M | $309.0M | ||
| Q1 25 | $65.0M | $296.7M | ||
| Q4 24 | $69.1M | $293.7M | ||
| Q3 24 | $51.6M | $283.1M | ||
| Q2 24 | $73.8M | $282.5M | ||
| Q1 24 | $137.7M | $270.6M |
净利润ESPRRVLV
| Q4 25 | — | $18.6M | ||
| Q3 25 | $-31.3M | $21.2M | ||
| Q2 25 | $-12.7M | $10.2M | ||
| Q1 25 | $-40.5M | $11.8M | ||
| Q4 24 | — | $12.3M | ||
| Q3 24 | $-29.5M | $11.0M | ||
| Q2 24 | $-61.9M | $15.4M | ||
| Q1 24 | $61.0M | $10.9M |
毛利率ESPRRVLV
| Q4 25 | — | 53.3% | ||
| Q3 25 | — | 54.6% | ||
| Q2 25 | — | 54.1% | ||
| Q1 25 | — | 52.0% | ||
| Q4 24 | — | 52.5% | ||
| Q3 24 | — | 51.2% | ||
| Q2 24 | — | 54.0% | ||
| Q1 24 | — | 52.3% |
营业利润率ESPRRVLV
| Q4 25 | 50.6% | 6.3% | ||
| Q3 25 | -11.4% | 7.1% | ||
| Q2 25 | 8.6% | 5.8% | ||
| Q1 25 | -34.0% | 5.0% | ||
| Q4 24 | -6.4% | 3.9% | ||
| Q3 24 | -31.0% | 5.0% | ||
| Q2 24 | 3.5% | 5.8% | ||
| Q1 24 | 52.5% | 3.4% |
净利率ESPRRVLV
| Q4 25 | — | 5.7% | ||
| Q3 25 | -35.9% | 7.2% | ||
| Q2 25 | -15.4% | 3.3% | ||
| Q1 25 | -62.2% | 4.0% | ||
| Q4 24 | — | 4.2% | ||
| Q3 24 | -57.2% | 3.9% | ||
| Q2 24 | -83.9% | 5.4% | ||
| Q1 24 | 44.3% | 4.0% |
每股收益（稀释后）ESPRRVLV
| Q4 25 | $0.32 | $0.27 | ||
| Q3 25 | $-0.16 | $0.29 | ||
| Q2 25 | $-0.06 | $0.14 | ||
| Q1 25 | $-0.21 | $0.16 | ||
| Q4 24 | $-0.14 | $0.18 | ||
| Q3 24 | $-0.15 | $0.15 | ||
| Q2 24 | $-0.33 | $0.21 | ||
| Q1 24 | $0.34 | $0.15 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $167.9M | $292.3M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-302.0M | $512.5M |
| 总资产 | $465.9M | $765.0M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ESPRRVLV
| Q4 25 | $167.9M | $292.3M | ||
| Q3 25 | $92.4M | $315.4M | ||
| Q2 25 | $86.1M | $310.7M | ||
| Q1 25 | $114.6M | $300.8M | ||
| Q4 24 | $144.8M | $256.6M | ||
| Q3 24 | $144.7M | $252.8M | ||
| Q2 24 | $189.3M | $244.7M | ||
| Q1 24 | $226.6M | $273.4M |
股东权益ESPRRVLV
| Q4 25 | $-302.0M | $512.5M | ||
| Q3 25 | $-451.4M | $490.2M | ||
| Q2 25 | $-433.5M | $468.6M | ||
| Q1 25 | $-426.2M | $453.4M | ||
| Q4 24 | $-388.7M | $437.8M | ||
| Q3 24 | $-370.2M | $420.8M | ||
| Q2 24 | $-344.2M | $405.8M | ||
| Q1 24 | $-294.3M | $389.9M |
总资产ESPRRVLV
| Q4 25 | $465.9M | $765.0M | ||
| Q3 25 | $364.0M | $751.3M | ||
| Q2 25 | $347.1M | $722.9M | ||
| Q1 25 | $324.0M | $713.9M | ||
| Q4 24 | $343.8M | $665.5M | ||
| Q3 24 | $314.1M | $670.9M | ||
| Q2 24 | $352.3M | $657.8M | ||
| Q1 24 | $373.1M | $650.0M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $45.2M | $-10.2M |
| 自由现金流经营现金流 - 资本支出 | — | $-13.3M |
| 自由现金流率自由现金流/营收 | — | -4.1% |
| 资本支出强度资本支出/营收 | 0.0% | 1.0% |
| 现金转化率经营现金流/净利润 | — | -0.55× |
| 过去12个月自由现金流最近4个季度 | — | $48.0M |
8季度趋势，按日历期对齐
经营现金流ESPRRVLV
| Q4 25 | $45.2M | $-10.2M | ||
| Q3 25 | $-4.3M | $11.8M | ||
| Q2 25 | $-31.4M | $12.6M | ||
| Q1 25 | $-22.6M | $45.1M | ||
| Q4 24 | $-35.0M | $3.9M | ||
| Q3 24 | $-35.3M | $9.1M | ||
| Q2 24 | $-7.2M | $-24.7M | ||
| Q1 24 | $53.8M | $38.4M |
自由现金流ESPRRVLV
| Q4 25 | — | $-13.3M | ||
| Q3 25 | — | $7.5M | ||
| Q2 25 | — | $10.4M | ||
| Q1 25 | — | $43.4M | ||
| Q4 24 | — | $2.1M | ||
| Q3 24 | $-35.5M | $8.0M | ||
| Q2 24 | $-7.3M | $-25.7M | ||
| Q1 24 | $53.8M | $36.7M |
自由现金流率ESPRRVLV
| Q4 25 | — | -4.1% | ||
| Q3 25 | — | 2.5% | ||
| Q2 25 | — | 3.4% | ||
| Q1 25 | — | 14.6% | ||
| Q4 24 | — | 0.7% | ||
| Q3 24 | -68.7% | 2.8% | ||
| Q2 24 | -9.9% | -9.1% | ||
| Q1 24 | 39.0% | 13.5% |
资本支出强度ESPRRVLV
| Q4 25 | 0.0% | 1.0% | ||
| Q3 25 | 0.0% | 1.5% | ||
| Q2 25 | 0.0% | 0.7% | ||
| Q1 25 | 0.0% | 0.6% | ||
| Q4 24 | 0.0% | 0.6% | ||
| Q3 24 | 0.3% | 0.4% | ||
| Q2 24 | 0.1% | 0.4% | ||
| Q1 24 | 0.1% | 0.6% |
现金转化率ESPRRVLV
| Q4 25 | — | -0.55× | ||
| Q3 25 | — | 0.56× | ||
| Q2 25 | — | 1.24× | ||
| Q1 25 | — | 3.82× | ||
| Q4 24 | — | 0.32× | ||
| Q3 24 | — | 0.83× | ||
| Q2 24 | — | -1.60× | ||
| Q1 24 | 0.88× | 3.53× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
RVLV
| Fashion Apparel | $155.1M | 48% |
| Dresses | $76.4M | 24% |
| Handbags Shoes And Accessories | $67.6M | 21% |
| Beauty | $20.3M | 6% |
| Manufactured Product Other | $5.0M | 2% |
| Breakage On Store Credit And Gift Cards | $900.0K | 0% |
